CN112390744A - Synthesis method of 6-methoxypyridine-3-methyl formate - Google Patents

Synthesis method of 6-methoxypyridine-3-methyl formate Download PDF

Info

Publication number
CN112390744A
CN112390744A CN202011392449.9A CN202011392449A CN112390744A CN 112390744 A CN112390744 A CN 112390744A CN 202011392449 A CN202011392449 A CN 202011392449A CN 112390744 A CN112390744 A CN 112390744A
Authority
CN
China
Prior art keywords
methoxypyridine
methyl
mass ratio
methanol
reduced pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011392449.9A
Other languages
Chinese (zh)
Inventor
赵小林
崔家乙
汪金柱
艾杨保
任勇杰
后士宝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NANJING HABO MEDICAL TECHNOLOGY CO LTD
Original Assignee
NANJING HABO MEDICAL TECHNOLOGY CO LTD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NANJING HABO MEDICAL TECHNOLOGY CO LTD filed Critical NANJING HABO MEDICAL TECHNOLOGY CO LTD
Priority to CN202011392449.9A priority Critical patent/CN112390744A/en
Publication of CN112390744A publication Critical patent/CN112390744A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/803Processes of preparation

Abstract

The invention discloses a synthesis method of 6-methoxypyridine-3-methyl formate, which comprises the steps of taking 2-chloronicotinic acid as a main raw material, taking methanol as a solvent, a methylating agent and concentrated sulfuric acid as a catalyst, and preparing an intermediate through an esterification reaction; the intermediate takes methanol as a solvent and sodium methoxide as alkali to replace halogen, so as to obtain 6-methoxypyridine-3-methyl formate; the whole process has the advantages of simple and easily obtained raw materials, simple and easy operation and good economic benefit.

Description

Synthesis method of 6-methoxypyridine-3-methyl formate
Technical Field
The invention belongs to the field of organic synthesis, and particularly relates to a synthesis method of 6-methoxypyridine-3-methyl formate.
Background
Pyridine medicine is a widely used medicine, such as antiphlogistic, anticancer, hypotensive, diabetes and other medicines. Also can be applied to biology, pesticide and the like, such as herbicide, cotton bollworm drug and the like. 6-methoxypyridine-3-methyl formate is an important chemical intermediate, is used as one of pyridine medicine intermediates, and is widely applied to biology and medicines. Regarding the synthesis of 6-methoxypyridine-3-methyl formate, the first report shows that 2-chloronicotinic acid is used as a main raw material, methanol is used as a solvent, a methylating agent and concentrated sulfuric acid are used as catalysts, and an intermediate is prepared through an esterification reaction; the intermediate takes methanol as a solvent and sodium methoxide as alkali to replace halogen to prepare a target product, and the whole process has the advantages of simple and easily obtained raw materials, simple and easy operation and good economic benefit.
Disclosure of Invention
In order to solve the problems, the invention discloses a synthesis method of 6-methoxypyridine-3-methyl formate, which has the advantages of simple and easily obtained raw materials, easily controlled reaction, no high-pressure dangerous operation, no dangerous solvent and simple post-treatment.
In order to achieve the purpose, the invention provides the following technical scheme:
a synthetic method of 6-methoxypyridine-3-methyl formate comprises the following steps:
(1) sequentially adding methanol, 6-chloronicotinic acid and concentrated sulfuric acid, heating to reflux, carrying out reflux reaction for 6 hours, then carrying out reduced pressure concentration, slowly adding the concentrated solution into ice water, and adding an aqueous sodium hydroxide solution to adjust the pH value; extracting with dichloromethane for three times, combining organic phases, concentrating under reduced pressure, and pulping the concentrated crude product with petroleum ether to obtain an intermediate;
Figure 100002_DEST_PATH_IMAGE002
(2) sequentially adding methanol, sodium methoxide and the intermediate prepared in the step (1), heating to reflux, carrying out reflux reaction for 10 hours, then carrying out reduced pressure concentration, slowly adding the concentrated solution into ice water, extracting with dichloromethane for three times, combining organic phases, carrying out reduced pressure concentration, and pulping the concentrated crude product with petroleum ether to obtain 6-methoxypyridine-3-methyl formate;
Figure 100002_DEST_PATH_IMAGE004
further, the mass ratio of the methanol to the concentrated sulfuric acid to the 6-chloronicotinic acid in the step (1) is 3.5-4.5: 0.05-0.15: 1.
Furthermore, the mass ratio of the dichloromethane and the 6-chloronicotinic acid added in each step in the step (1) is 4.5-5.5: 1.
Further, the pH value in the step (1) is 7-10; the concentration of the sodium hydroxide aqueous solution was 20%.
Further, the mass ratio of the petroleum ether to the 6-chloronicotinic acid in the step (1) is 1.5-2.4: 1.
Further, the mass ratio of the methanol and the sodium methoxide in the step (2) to the intermediate obtained in the step (1) is 3.5-4.5: 0.3-0.4: 1.
Further, the mass ratio of the ice water to the concentrated solution in the step (2) is 4-5: 1.
Further, the mass ratio of the dichloromethane added in each step in the step (2) to the intermediate obtained in the step (1) is 3-5: 1.
Further, the mass ratio of the petroleum ether in the step (2) to the intermediate obtained in the step (1) is 1-2: 1
Compared with the prior art, the invention has the following advantages and beneficial effects:
the synthesis method provided by the invention has the advantages of simple and easily obtained raw materials, easily controlled reaction, no high-pressure dangerous operation, no dangerous solvent, simple post-treatment, simple and easy operation and good economic benefit.
Detailed Description
The technical solutions provided by the present invention will be described in detail below with reference to specific examples, and it should be understood that the following specific embodiments are only illustrative of the present invention and are not intended to limit the scope of the present invention.
Example 1
(1) 1.2kg of methanol, 315g of 6-chloronicotinic acid and 31.5g of concentrated sulfuric acid are sequentially added into a 5L reaction bottle, heated to reflux and reacted for 6 hours under heat preservation. The reaction solution was concentrated under reduced pressure to a small volume and slowly added to 1.5kg of ice water. And adjusting the pH value of the system to 8-9 by using a 20% sodium hydroxide aqueous solution. It is extracted three times with 2kg of dichloromethane each time. And combining organic phases, and concentrating under reduced pressure at 40-50 ℃ to obtain a crude product. The crude product is pulped by 600g of petroleum ether to obtain 286g of intermediate in the first step, the yield is 83.3 percent, and the purity is 98 percent.
(2) 1.2kg of methanol, 130g of sodium methoxide and 343.2g of first-step intermediate are sequentially added into a 5L reaction bottle, heated to reflux and kept for reaction for 10 hours. The reaction solution was concentrated under reduced pressure to a small volume and slowly added to 1.5kg of ice water. It is extracted three times with 2kg of dichloromethane each time. Mixing organic phases, and concentrating at 40-50 deg.C under reduced pressure to obtain crude product. The crude product is pulped by 500g of petroleum ether to obtain 273g of product, the yield is 81.6 percent, and the purity is 98 percent.
Example 2
The process was scaled up according to the reaction conditions of example 1, with the specific steps:
(1) 48kg of methanol, 12.6kg of 6-chloronicotinic acid and 1.26kg of concentrated sulfuric acid are sequentially added into a 100L reaction kettle, heated to reflux and reacted for 8 hours under heat preservation. The reaction solution was concentrated under reduced pressure to a small volume and slowly added to 60kg of ice water. And adjusting the pH value of the system to 8-9 by using a 20% sodium hydroxide aqueous solution. It was extracted three times with 60kg of dichloromethane each time. And combining organic phases, and concentrating under reduced pressure at 40-50 ℃ to obtain a crude product. The crude product is pulped by 24kg of petroleum ether to obtain 11.62kg of the intermediate in the first step, the yield is 84.6 percent, and the purity is 98 percent.
(2) 48kg of methanol, 5.2kg of sodium methoxide and 13.73kg of first-step intermediate are sequentially added into a 100L reaction kettle, heated to reflux and kept for reaction for 16 hours. The reaction solution was concentrated under reduced pressure to a small volume and slowly added to 60kg of ice water. It was extracted three times with 60kg of dichloromethane each time. And combining organic phases, and concentrating under reduced pressure at 40-50 ℃ to obtain a crude product. The crude product is pulped by 22kg of petroleum ether to obtain 11.12kg of product, the yield is 83.1 percent, and the purity is 98 percent.
As can be seen from example 2, the synthesis process of the invention is stable, has repeatability and is suitable for industrial production.
The technical means disclosed in the invention scheme are not limited to the technical means disclosed in the above embodiments, but also include the technical scheme formed by any combination of the above technical features. It should be noted that those skilled in the art can make various improvements and modifications without departing from the principle of the present invention, and such improvements and modifications are also considered to be within the scope of the present invention.

Claims (9)

1. A synthetic method of 6-methoxypyridine-3-methyl formate is characterized by comprising the following steps:
(1) sequentially adding methanol, 6-chloronicotinic acid and concentrated sulfuric acid, heating to reflux, carrying out reflux reaction for 6 hours, then carrying out reduced pressure concentration, slowly adding the concentrated solution into ice water, and adding an aqueous sodium hydroxide solution to adjust the pH value; extracting with dichloromethane for three times, combining organic phases, concentrating under reduced pressure, and pulping the concentrated crude product with petroleum ether to obtain an intermediate;
Figure DEST_PATH_IMAGE002
(2) sequentially adding methanol, sodium methoxide and the intermediate prepared in the step (1), heating to reflux, carrying out reflux reaction for 10 hours, then carrying out reduced pressure concentration, slowly adding the concentrated solution into ice water, extracting with dichloromethane for three times, combining organic phases, carrying out reduced pressure concentration, and pulping the concentrated crude product with petroleum ether to obtain 6-methoxypyridine-3-methyl formate;
Figure DEST_PATH_IMAGE004
2. the method for synthesizing methyl 6-methoxypyridine-3-carboxylate according to claim 1, wherein the mass ratio of methanol to concentrated sulfuric acid to 6-chloronicotinic acid in the step (1) is 3.5-4.5: 0.05-0.15: 1.
3. The method for synthesizing methyl 6-methoxypyridine-3-carboxylate according to claim 1, wherein the mass ratio of dichloromethane to 6-chloronicotinic acid added in each step (1) is 4.5-5.5: 1.
4. The synthesis method of methyl 6-methoxypyridine-3-carboxylate according to claim 1, wherein the pH in step (1) is 7 to 10; the concentration of the sodium hydroxide aqueous solution was 20%.
5. The method for synthesizing methyl 6-methoxypyridine-3-carboxylate according to claim 1, wherein the mass ratio of the petroleum ether to the 6-chloronicotinic acid in the step (1) is 1.5 to 2.4: 1.
6. The method for synthesizing 6-methoxypyridine-3-carboxylic acid methyl ester according to claim 1, wherein the mass ratio of methanol to sodium methoxide to the intermediate obtained in step (1) in step (2) is 3.5 to 4.5:0.3 to 0.4: 1.
7. The synthesis method of methyl 6-methoxypyridine-3-carboxylate according to claim 1, wherein the mass ratio of ice water to the concentrated solution in the step (2) is 4-5: 1.
8. The method for synthesizing methyl 6-methoxypyridine-3-carboxylate according to claim 1, wherein the mass ratio of dichloromethane added in each step (2) to the intermediate obtained in step (1) is 3-5: 1.
9. The synthesis method of methyl 6-methoxypyridine-3-carboxylate according to claim 1, wherein the mass ratio of the petroleum ether in the step (2) to the intermediate obtained in the step (1) is 1-2: 1.
CN202011392449.9A 2020-12-02 2020-12-02 Synthesis method of 6-methoxypyridine-3-methyl formate Pending CN112390744A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011392449.9A CN112390744A (en) 2020-12-02 2020-12-02 Synthesis method of 6-methoxypyridine-3-methyl formate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011392449.9A CN112390744A (en) 2020-12-02 2020-12-02 Synthesis method of 6-methoxypyridine-3-methyl formate

Publications (1)

Publication Number Publication Date
CN112390744A true CN112390744A (en) 2021-02-23

Family

ID=74604971

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011392449.9A Pending CN112390744A (en) 2020-12-02 2020-12-02 Synthesis method of 6-methoxypyridine-3-methyl formate

Country Status (1)

Country Link
CN (1) CN112390744A (en)

Similar Documents

Publication Publication Date Title
CN111704555A (en) Method for synthesizing 4-methoxy-2-nitroaniline by adopting continuous flow reactor
CN113956312A (en) Preparation method of mopilavir
CN110862323A (en) Synthesis method of diaminodiphenylethane compound
CN109096122B (en) Process for preparing spermidine
CN101607892A (en) The production method of Sodium Citrate
CN112390744A (en) Synthesis method of 6-methoxypyridine-3-methyl formate
CN115820762A (en) Process for the synthesis of (S) -nicotine and intermediates thereof
CN109535210A (en) A kind of method of synthesizing and purifying Tulathromycin impurity E
CN101709050B (en) New method for synthesizing 2, 5-dichloropyridine
CN112592262A (en) Preparation method of adamantanone
CN113582918A (en) Method for preparing 2,3-dichloropyridine by chlorination
CN112552231A (en) Synthetic method of 2- (3-chloro-5- (trifluoromethyl) pyridine-2-yl) ethylamine
CN112300027B (en) Preparation method of amino butyronitrile
CN108997138A (en) A kind of method of solvent-free catalytic hydrogenation production para-fluoroaniline
CN112920249B (en) Industrial method for preparing stigmasterol
CN117466810B (en) Industrial continuous production method of picloram
CN115536494B (en) Synthesis method of 1- (4-bromophenyl) -1, 4-butanediol
CN112979560B (en) Method for preparing uracil
CN113563230B (en) Preparation method of propamocarb hydrochloride technical
CN114249352B (en) Method for treating wastewater generated in production of 6-methoxy tetralone
CN110437113B (en) Synthesis method of 4-benzenesulfonylbenzoic acid
CN109111371B (en) Preparation method of hydrazino ethyl acetate hydrochloride
CN108069897B (en) Method for synthesizing nicotinic acid by using carbon dioxide
CN105622381A (en) Atovaquone synthesis technology
CN108003122A (en) A kind of synthetic method of 4- amino tetrahydro pyrans

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication